Phagenesis
Founded in 2007, Phagenesis is committed to scientific and clinical excellence in the development of novel therapies to treat patients suffering from neurogenic dysphagia.
The foundational science and clinical evidence for the Pharyngeal Electrical Stimulation used in Phagenyx has been peer reviewed and published at the highest level.
First to map the swallow motor cortex in health & disease.
First to show that dysphagia recovery is due to functional reorganization of the swallow motor cortex.
First to show that long-term reorganization of the cortex can be driven by short term sensory stimulation.
First to show that sensory stimulation driven reorganization results in functional swallow recovery.
First in a multicenter RCT to show that Phagenyx® responders had a statistically significant shorter length of stay versus non-responders.
First to demonstrate in a multicenter registry of real-world data clinically significant improvements in CNS, nonCNS, mechanically ventilated, and non-ventilated patients using a range of dysphagia outcome measures.
